stars 1 stars 2 stars 3

STCube is a clinical-stage biotechnology company focused on the discovery and development of first-in-class cancer immunotherapies. The company is advancing novel immune checkpoint inhibitors, including programs targeting BTN1A1, to address patients who do not benefit from existing PD-1/PD-L1 therapies. Leveraging biomarker-driven development strategies, STCube is conducting multiple clinical studies to evaluate the safety and efficacy of its lead assets across solid tumors. The company aims to deliver innovative treatment options for patients with high unmet medical needs through strategic global partnerships and scientifically differentiated pipelines.

STCube, Inc. Questions

2 people are employed at STCube, Inc..

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users